4,096 research outputs found
Astrocytes in neuroendocrine systems: An overview
This is the author accepted manuscript. The final version is available from Wiley via the DOI in this record A class of glial cell, astrocytes are highly abundant in the CNS. In addition to maintaining tissue homeostasis, astrocytes regulate neuronal communication and synaptic plasticity. There is an ever-increasing appreciation that astrocytes are involved in the regulation of physiology and behaviour in normal and pathological states, including within neuroendocrine systems. Indeed, astrocytes are direct targets of hormone action in the CNS, via receptors expressed on their surface, and are also a source of regulatory neuropeptides, neurotransmitters, and gliotransmitters. Furthermore, as part of the neurovascular unit, astrocytes can regulate hormone entry into the CNS. This review is intended to provide an overview of how astrocytes are impacted by and contribute to the regulation of a diverse range of neuroendocrine systems: energy homeostasis and metabolism, reproduction, fluid homeostasis, the stress response, and circadian rhythms. This article is protected by copyright. All rights reserved.Medical Research Council (MRC)Diabetes UKUniversity of Exete
Assembly of alpha-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of alpha-synuclein seeds
Peripheral administration (oral, intranasal, intraperitoneal, intravenous) of assembled A53T α-synuclein induced synucleinopathy in heterozygous mice transgenic for human mutant A53T α-synuclein (line M83). The same was the case when cerebellar extracts from a case of multiple system atrophy with type II α-synuclein filaments were administered intraperitoneally, intravenously or intramuscularly. We observed abundant immunoreactivity for pS129 α-synuclein in nerve cells and severe motor impairment, resulting in hindlimb paralysis and shortened lifespan. Filaments immunoreactive for pS129 α-synuclein were in evidence. A 70% loss of motor neurons was present five months after an intraperitoneal injection of assembled A53T α-synuclein or cerebellar extract with type II α-synuclein filaments from an individual with a neuropathologically confirmed diagnosis of multiple system atrophy. Microglial cells changed from a predominantly ramified to a dystrophic appearance. Taken together, these findings establish a close relationship between the formation of α-synuclein inclusions in nerve cells and neurodegeneration, accompanied by a shift in microglial cell morphology. Propagation of α-synuclein inclusions depended on the characteristics of both seeds and transgenically expressed protein
Correlation Functions in 2-Dimensional Integrable Quantum Field Theories
In this talk I discuss the form factor approach used to compute correlation
functions of integrable models in two dimensions. The Sinh-Gordon model is our
basic example. Using Watson's and the recursive equations satisfied by matrix
elements of local operators, I present the computation of the form factors of
the elementary field and the stress-energy tensor of
the theory.Comment: 19pp, LATEX version, (talk at Como Conference on ``Integrable Quantum
Field Theories''
Confirmation of low genetic diversity and multiple breeding females in a social group of Eurasian badgers from microsatellite and field data
The Eurasian badger (
Meles meles
) is a facultatively social carnivore that shows only rudimentary
co-operative behaviour and a poorly defined social hierarchy. Behavioural evidence
and limited genetic data have suggested that more than one female may breed in a
social group. We combine pregnancy detection by ultrasound and microsatellite locus
scores from a well-studied badger population from Wytham Woods, Oxfordshire, UK, to
demonstrate that multiple females reproduce within a social group. We found that at least
three of seven potential mothers reproduced in a group that contained 11 reproductive age
females and nine offspring. Twelve primers showed variability across the species range and only five of these were variable in Wytham. The microsatellites showed a reduced repeat number, a significantly higher number of nonperfect repeats, and moderate heterozygosity
levels in Wytham. The high frequency of imperfect repeats and demographic phenomena might be responsible for the reduced levels of variability observed in the badger
Prevention programmes for children of problem drinkers: a review
It is well established that children of problem drinkers have an increased risk of developing mental health problems, including drinking and drug misuse problems, depression, eating disorders, conduct disorders, and delinquency. However, compared to the hundreds of studies that have examined the effects of parental problem drinking on their children, the genetics of problem drinking, and the physical and mental problems of these children, it is disappointing that so few studies have explored the possibilities of prevention. Despite all the research on children of problem drinkers, we have no usable operationalizations of what problem drinking is, or when a child can be defined as a child of a problem drinker. Furthermore, no valid screening or severity assessment instruments are available; there is no solution for the ethical dilemma of the need to involve parents while these parents are at the same time the problem; very few theory-driven prevention programmes have been developed; very little is known about protective factors that could be the focus of prevention programmes; and we have no programmes that can be considered to be ‘evidence based’. This paper describes these problems, presents an overview of the prevention research in this area, and gives some directions for future research
Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial.
BACKGROUND:Delirium is highly problematic in palliative care (PC). Preliminary data indicate a potential role for melatonin to prevent delirium, but no randomized controlled trials (RCTs) are reported in PC. METHODS:Patients aged ≥18 years, with advanced cancer, admitted to an inpatient Palliative Care Unit (PCU), having a Palliative Performance Scale rating ≥ 30%, and for whom consent was obtained, were included in the study. Patients with delirium on admission were excluded. The main study objectives were to assess the feasibility issues of conducting a double-blind RCT of exogenous melatonin to prevent delirium in PC: recruitment, retention, procedural acceptability, appropriateness of outcome measures, and preliminary efficacy and safety data. Study participants were randomized in a double-blind, parallel designed study to receive daily melatonin 3 mg or placebo orally at 21:00 over 28 days or less if incident delirium, death, discharge or withdrawal occurred earlier. Delirium was diagnosed using the Confusion Assessment Method. Efficacy endpoints in the melatonin and placebo groups were compared using time-to-event analysis: days from study entry to onset of incident delirium. RESULTS:Over 16 months, 60/616 (9.7%; 95% CI: 7.5-12.4%) screened subjects were enrolled. The respective melatonin (n = 30) vs placebo (n = 30) outcomes were: incident delirium in 11/30 (36.7%; 95%CI: 19.9-56.1%) vs 10/30 (33%; 95% CI: 17.3-52.8%); early discharge (6 vs 5); withdrawal (6 vs 3); death (0 vs 1); and 7 (23%) vs 11 (37%) reached the 28-day end point. The 25th percentile time-to-event were 9 and 18 days (log rank, χ2 = 0.62, p = 0.43) in melatonin and placebo groups, respectively. No serious trial medication-related adverse effects occurred and the core study procedures were acceptable. Compared to those who remained delirium-free during their study participation, those who developed delirium (n = 21) had poorer functional (p = 0.036) and cognitive performance (p = 0.013), and in particular, poorer attentional capacity (p = 0.003) at study entry. CONCLUSIONS:A larger double-blind RCT is feasible, but both subject accrual and withdrawal rates signal a need for multisite collaboration. The apparent trend for shorter time to incident delirium in the melatonin group bodes for careful monitoring in a larger trial. TRIAL REGISTRATION:Registered on July 21st 2014 with ClinicalTrials.gov : NCT02200172
Insulators and imprinting from flies to mammals
The nuclear factor CTCF has been shown to be necessary for the maintenance of genetic imprinting at the mammalian H19/Igf2 locus. MacDonald and colleagues now report in BMC Biology that the mechanisms responsible for maintaining the imprinted state in Drosophila may be evolutionarily conserved and that CTCF may also play a critical role in this process
Acute lymphoblastic leukemia subsequent to temozolomide use in a 26-year-old man: a case report
<p>Abstract</p> <p>Introduction</p> <p>We report the development of acute lymphoblastic leukemia in a patient in whom temozolomide was used for the treatment of a brain tumor. Unlike that of other alkylating agents, the leukemogenic potential of temozolomide is considered to be very low, and very rarely are such cases reported.</p> <p>Case Presentation</p> <p>A 26-year-old Pakistani man who was treated for glioblastoma with temozolomide in an adjuvant setting was diagnosed to have acute lymphoblastic leukemia one year after stopping temozolomide.</p> <p>Conclusion</p> <p>Temozolomide is a highly active agent, used in the management of high-grade brain neoplasms. The agent is generally regarded to be safe, with an acceptable safety profile. Very few cases of myelodysplasia associated with temozolomide use have been reported. We report here the first case of acute lymphoblastic leukemia, which developed in a young man about one year after he finished taking temozolomide. This should provide further insight into a possible toxicity profile of this alkylating agent. This finding should be of interest to physicians in general and to medical oncologists in particular.</p
Identification of the factors associated with outcomes in a condition management programme
<p>Background: A requirement of the Government’s Pathways to Work (PtW) agenda was to introduce a Condition Management Programme (CMP). The aim of the present study was to identify the differences between those who engaged and made progress in this telephone-based biopsychosocial intervention, in terms of their health, and those who did not and to determine the client and practitioner characteristics and programme elements associated with success in a programme aimed at improving health.</p>
<p>Methods: Data were obtained from the CMP electronic spreadsheets and clients paper-based case records. CMP
standard practice was that questionnaires were administered during the pre- and post-assessment phases over the
telephone. Each client’s record contains their socio-demographic data, their primary health condition, as well as the pre- and post-intervention scores of the health assessment tool administered. Univariate and multivariate statistical analysis was used to investigate the relationships between the database variables. Clients were included in the study if their records were available for analysis from July 2006 to December 2007.</p>
<p> Results: On average there were 112 referrals per month, totalling 2016 referrals during the evaluation period. The
majority (62.8%) of clients had a mental-health condition. Successful completion of the programme was 28.5% (575
“completers”; 144 “discharges”). Several factors, such as age, health condition, mode of contact, and practitioner
characteristics, were significant determinants of participation and completion of the programme. The results
showed that completion of the CMP was associated with a better mental-health status, by reducing the number of
clients that were either anxious, depressed or both, before undertaking the programme, from 74% to 32.5%.</p>
<p>Conclusions: Our findings showed that an individual's characteristics are associated with success in the
programme, defined as completing the intervention and demonstrating an improved health status. This study
provides some evidence that the systematic evaluation of such programmes and interventions could identify ways
in which they could be improved.</p>
Trace as an alternative decategorification functor
Categorification is a process of lifting structures to a higher categorical
level. The original structure can then be recovered by means of the so-called
"decategorification" functor. Algebras are typically categorified to additive
categories with additional structure and decategorification is usually given by
the (split) Grothendieck group. In this expository article we study an
alternative decategorification functor given by the trace or the zeroth
Hochschild--Mitchell homology. We show that this form of decategorification
endows any 2-representation of the categorified quantum sl(n) with an action of
the current algebra U(sl(n)[t]) on its center.Comment: 47 pages with tikz figures. arXiv admin note: text overlap with
arXiv:1405.5920 by other author
- …